CervoMed (CRVO) EBIAT (2022 - 2025)
Historic EBIAT for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$7.7 million.
- CervoMed's EBIAT fell 6254.49% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.6 million, marking a year-over-year decrease of 11415.09%. This contributed to the annual value of -$16.3 million for FY2024, which is 65007.59% down from last year.
- As of Q3 2025, CervoMed's EBIAT stood at -$7.7 million, which was down 6254.49% from -$6.3 million recorded in Q2 2025.
- In the past 5 years, CervoMed's EBIAT registered a high of $2.2 million during Q3 2023, and its lowest value of -$7.7 million during Q3 2025.
- Its 4-year average for EBIAT is -$3.1 million, with a median of -$2.4 million in 2023.
- Its EBIAT has fluctuated over the past 5 years, first surged by 34363.31% in 2023, then plummeted by 37055.32% in 2024.
- Over the past 4 years, CervoMed's EBIAT (Quarter) stood at -$1.5 million in 2022, then crashed by 54.67% to -$2.4 million in 2023, then tumbled by 183.86% to -$6.7 million in 2024, then decreased by 15.22% to -$7.7 million in 2025.
- Its EBIAT was -$7.7 million in Q3 2025, compared to -$6.3 million in Q2 2025 and -$4.9 million in Q1 2025.